PHARMACOKINETICS OF 2 LORAZEPAM FORMULATIONS, ORAL AND SUBLINGUAL, AFTER MULTIPLE DOSES

被引：22

作者：

CAILLE, G

SPENARD, J

LACASSE, Y

BRENNAN, J

机构：

来源：

BIOPHARMACEUTICS & DRUG DISPOSITION | 1983年 / 4卷 / 01期

关键词：

D O I：

10.1002/bdd.2510040106

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：31 / 42

页数：12

共 8 条

[1]

CAILLE G, 1980, ADV NEUROTOXICOLOGY, P375

[2]

DIXON WJ, 1979, BMDP 3AR BIOMEDICAL

[3]

GIBALDI M, 1975, PHARMACOKINETICS, P110

[4]

GREENBLATT DJ, 1977, CLIN PHARMACOL THER, V21, P222

[5]

GREENBLATT DJ, 1976, CLIN PHARMACOL THER, V20, P329

[6] CLINICAL PHARMACOKINETICS OF LORAZEPAM .3. INTRAVENOUS-INJECTION - PRELIMINARY-RESULTS [J].

GREENBLATT, DJ ;

COMER, WH ;

ELLIOTT, HW ;

SHADER, RI ;

KNOWLES, JA ;

RUELIUS, HW .

JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (8-9) :490-494

[7] PHARMACOKINETICS AND BIOAVAILABILITY OF INTRAVENOUS, INTRAMUSCULAR, AND ORAL LORAZEPAM IN HUMANS [J].

GREENBLATT, DJ ;

SHADER, RI ;

FRANKE, K ;

MACLAUGHLIN, DS ;

HARMATZ, JS ;

ALLEN, MD ;

WERNER, A ;

WOO, E .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (01) :57-63

[8]

WAGNER JG, 1975, FUNDAMENTALS CLIN PH

← 1 →